Companie Making Automated Drug Discovery a Reality
Data is king in modern biopharmaceutical research, and ability to generate massive amounts of quality biomedical data represents a tremendous research …
All Posts
Advancing Cell-free Biocomputing
Researchers from the University of Minnesota have published a study in Nature Communications introducing a new biocomputing method, Transcriptional RNA …
AI Drug Discovery: Key Trends and Developments in Pharmaceutical Industry
AI in Drug Discovery at a Glance The ongoing rise of artificial intelligence (AI) is significantly impacting various industries, with …
19 Life Science Marketplaces Enabling Research
(This article was first published in 2017 and has been updated in July 2022) Life science marketplace is an online platform that operate with …
From Qubits to Cures: The Promise of Quantum Computing in Pharmaceutical Research and Development (a Realistic View)
In a recent announcement, Moderna and IBM unveiled their partnership aimed at utilizing cutting-edge technologies, such as artificial intelligence (AI) …
The Power of STB CLOUD in Remote AI Drug Discovery
STB CLOUD is Syntekabio’s latest cloud-based, fully automated AI platform. It’s designed for developers to engage in their drug discovery …
AI Drug Discovery: Unleashing the Potential of Big Data and Machine Learning
The terms “big data”, “machine learning”, and “artificial intelligence” have been trending in the AI drug discovery space for several …
RetinAI and Boehringer Ingelheim Collaborate on AI-Driven Drug Discovery for Geographic Atrophy Treatment
Established in 2017 in Swiss, RetinAI Medical AG is a notable player in clinical and imaging data management software and …
Myricx Pharma Showcases Promising Pre-Clinical Data for NMTi ADC Programme at AACR
Myricx Pharma, an oncology drug discovery company specializing in precision medicines based on its N-myristoyltransferase (NMT) platform, has recently presented …
Enamine and Endogena's Persistent Collaboration Paves the Way for Regenerative Medicine Advancements
In a world where innovation and collaboration play a critical role in the development of cutting-edge therapies, Enamine Ltd. and …
Macomics Unveils ENIGMAC™ Discovery Platform at AACR for Target Validation in Macrophage Therapies
Macomics Ltd, a frontrunner in macrophage drug discovery, recently showcased its innovative ENIGMAC™ macrophage drug discovery platform at the American …
Reimagining Genomics Data Analysis: Interview with Paolo Di Tommaso from Seqera Labs
With BioNTech’s recent $200 million merger with OncoC4’s cancer drug, the demand for personalised medicines to treat diseases such as cancer …
